Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6

L M Tuyt1, W H Dokter, K Birkenkamp

  • 1Division of Hematology, Department of Medicine, University of Groningen, The Netherlands.

Insights

Mitogen-activated protein kinase pathways, including extracellular-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK), activate NF-kappa B transcriptional capacity, driving IL-6 gene expression in human monocytes.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Interleukin-6 (IL-6) is a key cytokine involved in immune responses and inflammation.
  • NF-kappa B is a crucial transcription factor regulating the expression of numerous genes, including IL-6.
  • Mitogen-activated protein kinase (MAPK) pathways, such as ERK and JNK, are implicated in cellular signaling.

Purpose of the Study:

  • To investigate the role of ERK1/2 and JNK pathways in IL-6 gene expression in human monocytes.
  • To elucidate the involvement of these MAPK pathways in modulating NF-kappa B activity.
  • To determine the specific mechanisms by which ERK1/2 and JNK influence IL-6 transcription.

Main Methods:

  • Human monocytes were treated with okadaic acid to induce IL-6 secretion.
  • NF-kappa B binding activity, ERK1/2, and JNK phosphorylation/activation were assessed.
  • Specific inhibitors (PD98059) and dominant-negative mutants (Raf-1, JNK1) were used to probe pathway involvement.
  • IL-6 promoter activity and NF-kappa B-mediated transcription were analyzed.

Main Results:

  • Okadaic acid treatment increased IL-6 secretion, NF-kappa B activity, and ERK1/2/JNK activation.
  • Inhibition of the ERK pathway (PD98059) reduced IL-6 secretion.
  • Both ERK and JNK pathways were essential for NF-kappa B-dependent IL-6 promoter activity.
  • The ERK1/2 pathway enhanced NF-kappa B transcriptional activity, not DNA binding.
  • NF-kappa B transcription required serine kinase activity and c-Jun interaction, with JNK potentially phosphorylating c-Jun.

Conclusions:

  • Okadaic acid-induced IL-6 expression is partly mediated by ERK1/2 and JNK pathways activating NF-kappa B transcriptional capacity.
  • The JNK pathway may regulate NF-kappa B-mediated transcription via c-Jun phosphorylation and activation.
  • These findings highlight the intricate crosstalk between MAPK signaling and NF-kappa B in controlling IL-6 production.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...